Adicet Bio Inc

ACETNASDAQ · USD
9.02USD0.00 (+9.07%)
555

Adicet Bio Inc (ACET) Covered Calls

As of September 25, 2026, ACET has 6 covered call opportunities in the coming three months. Return ranges from 14.2 to 100.1% until expiration. Annualized return ranges from 29.5 to 689.8%. The nearest expiration is October 16, 2026. Maximum potential profit is $903.

Read more

Running ACET covered calls helps you generate consistent income from Adicet Bio Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Adicet Bio Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ACET covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ACET stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ACET covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Adicet Bio Inc covered call is worth writing.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors.

Adicet Bio, Inc. is based in Boston, Massachusetts.

Income-focused investors, long-term ACET holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ACET covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Adicet Bio Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile36.90% Neutral
  • Market cap (M$)84
  • 52 weeks high-48.28%
  • 52 weeks low50.08%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$33.17
    267.74% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E—
  • Future P/E—
  • EPS (ttm)-11.53
  • EPS growth next 5 years63.24%

As of September 25, 2026

2026-10-162112.5038.580.102.45358.0039.69689.84-1.11+0.42242.35
2026-10-162110.0010.860.301.30128.0014.19246.65-3.33+0.44921.00
2027-04-1620317.5094.010.554.90903.00100.11180.00-6.10+0.543704.35
2027-04-1620315.0066.300.904.90688.0076.27137.14-9.98+0.5834.00
2027-04-1620312.5038.581.154.50463.0051.3392.29-12.75+0.5903.35
2027-04-1620310.0010.860.504.90148.0016.4129.50-5.54+0.6314.40

As of September 25, 2026

Sell covered calls with the data behind you

Find the best ACET covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial